ORCA
Online Research @ CardiffÂ
Browse by Current Cardiff authors
![[up]](/style/images/multi_up.png)
Up a levelNumber of items: 10.
| Leong, James, McAuslane, Neil, Walker, Stuart and Salek, Mir-saeed 2013. Is there a need for a universal benefit-risk assessment framework for medicines? Regulatory and industry perspectives. Pharmacoepidemiology and Drug Safety 22 (9) , pp. 1004-1012. 10.1002/pds.3464 |
|
| Al-Essa, Reem, Salek, Mir-saeed and Walker, Stuart 2012. Regulatory review process in the Gulf Cooperation Council states: similarities and differences. Drug Information Journal 46 (1) , pp. 65-72. 10.1177/0092861511427674 |
|
|
| Salek, Mir-saeed, Mallia-Milanes, Andrea, McAuslane, Neil and Walker, Stuart 2012. Development and application of scorecards to assess the quality of a regulatory submission and its review. Drug Information Journal 46 (1) , pp. 73-83. 10.1177/0092861511427694 |
|
|
| Al-Essa, Reem, Salek, Mir-saeed and Walker, Stuart 2012. An appraisal of good regulatory review practices in the Gulf Cooperation Council states. Drug Information Journal 46 (1) , pp. 57-64. 10.1177/0092861511427110 |
|
|
| Salek, Mir-saeed, Kamau, P., McAuslane, N, Pichler, F. and Walker, Stuart 2010. Is simultaneous submission and regulatory approval a reality towards faster patient access to medicines in the ICH region and beyond? [Abstract]. Pharmacy World and Science 32 (2) , pp. 218-219. 10.1007/s11096-010-9378-9 |
|
|
| Salek, Mir-saeed, Loh, E. A. T., McAuslane, N., Read, K. and Walker, Stuart 2009. Factors influencing delays of pharmaceutical product registration in new markets: a global concern [Abstract]. Pharmacy World & Science 31 (2) , pp. 277-278. 10.1007/s11096-008-9274-8 |
|
|
| Salek, Sam, Mallia-Milanes, A., McAuslane, N. and Walker, Stuart 2008. Can systematic use of scorecards be of value in the evaluation of the quality of industry submissions and their regulatory review? [Abstract]. Pharmacy World and Science 30 (5) , p. 721. 10.1007/s11096-008-9226-3 |
|
|
| Salek, Sam, Morgan, L., McAuslane, N., Read, K. and Walker, Stuart 2008. Companies submission strategies and regulatory approval times greatly influence patient access to medicine [Abstract]. Pharmacy World and Science 30 (5) , p. 720. 10.1007/s11096-008-9226-3 |
|
|
| Salek, Sam, Chauhan, A., Hirako, M., McAuslane, N. and Walker, Stuart 2007. Does the global increase in post-marketing commitment ensure faster patient access to novel medicines? [Abstract]. Pharmacy World and Science 29 (5) , p. 449. 10.1007/s11096-007-9098-y |
|
|
| Salek, Mir-saeed, Luscombe, David Keith, Walker, Stuart, Grob, P. R., Vandenburg, M. J. and Lewis, Malcolm John 1988. Cardiovascular-disease and quality of life [Abstract]. British Journal of Clinical Pharmacology 26 (5) , 628P-628P. |
|
|
Cardiff University Information Services